Please provide your email address to receive an email when new articles are posted on . The most common ophthalmic procedure is an intravitreal injection, with more than 10 million per year performed ...

Jose Martinez, MD: When we assess patients and we’re trying to consider whether to use anti-VEGF [anti-vascular endothelial growth factor], one thing we consider is their ability to come back and see ...

Findings of the PANORAMA randomized clinical trial show that when patients with severe nonproliferative diabetic retinopathy were treated with intravitreal aflibercept, severity improved over 100 ...

Intravitreal injections with aflibercept (Eylea) don't improve the visual acuity of people with nonproliferative diabetic retinopathy (NPDR), researchers say. The treatments do reduce the risk for ...

Early pars plana vitrectomy (PPV) using modern surgical tools demonstrated promising outcomes in patients who developed endophthalmitis after cataract surgery or intravitreal injection. Most regained ...

Repeat treatment with corticosteroid injections improved vision in people with persistent or recurrent uveitis-related macular edema better than two other therapies, according to results from a ...

New study from University of California, Irvine and University of California, Santa Barbara researchers demonstrates improved retinal function and vascular integrity, supporting further investigation ...

A dexamethasone implant significantly outperformed ranibizumab (Lucentis) and methotrexate for intravitreal treatment of persistent/recurrent uveitic macular edema, according to results of a ...

What is behind the bilateral eye pain and failing vision affecting a 96-year-old woman with neovascular age-related macular degeneration (nAMD)? That's what ophthalmologists needed to determine when ...